Brief: Biocartis Group NV - FY Total Operating Income Increased Year-Over-Year By 47% To EUR 55.6M

Biocartis NV

25/02/2021 06:39

Feb 25 (Reuters) - Biocartis Group NV  BCART.BR :
    * BIOCARTIS GROUP NV - FY TOTAL OPERATING INCOME INCREASED
YEAR-OVER-YEAR BY 47% TO EUR 55.6M
    * BIOCARTIS GROUP NV - FY PRODUCT SALES REVENUES AMOUNTED TO
EUR
31.9M (YEAR-OVER-YEAR INCREASE OF 32%)
    * BIOCARTIS GROUP NV - CASH AND CASH EQUIVALENTS AMOUNTED TO
EUR
124M AS AT 31 DECEMBER 2020
    * BIOCARTIS GROUP NV - 2021 WILL AGAIN BE MARKED BY
CONTINUED
IMPACT OF PANDEMIC
    * BIOCARTIS GROUP NV - OUTLOOK: COMMERCIAL CARTRIDGE VOLUME:
TARGETING A YEAR-OVER-YEAR GROWTH OF 40%-60% OR COMMERCIAL
CARTRIDGE VOLUMES IN THE RANGE OF 320K-370K
    * BIOCARTIS GROUP NV - COMMERCIAL CARTRIDGE VOLUME: HIGH-END
OF
RANGE WILL ONLY BE DELIVERED IN CASE OF CONSISTENT STRONG DEMAND
FOR IDYLLA SARS-COV-2 TEST AT ATTRACTIVE AVERAGE SELLING PRICES
THROUGHOUT 2021
    * BIOCARTIS GROUP NV - OUTLOOK: INSTALLED BASE: TARGETING
300-350
NEW IDYLLA INSTRUMENT PLACEMENTS
    * BIOCARTIS GROUP NV - CASH POSITION: TARGETING AT LEAST EUR
50M
CASH POSITION AT YEAR-END, INCLUDING POTENTIAL INVESTMENTS IN
UPGRADING AND EXPANDING INFECTIOUS DISEASES MENU
    * BIOCARTIS GROUP NV - FY OPERATING LOSS FOR 2020 AMOUNTED
TO EUR
46.9M, AN IMPROVEMENT OF EUR 8.7M OR 16% COMPARED TO 2019
    * BIOCARTIS GROUP NV - END 2020, TOTAL FINANCIAL DEBT
AMOUNTED TO
EUR 150.6M COMPARED TO EUR 166.6M END OF 2019

Source text for Eikon:  ID:nGNE9y56JC 
Further company coverage:  BCART.BR 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))